1. Deny to sign the informed consent; 
2. type 1 diabetes; 
3. Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L; 
4. Have severe liver disease, kidney disease or cancer; 
5. Participating in the other clinical trial within 30 days; 
6. Other diseases or conditions, for which the doctor of the patients do not agree his or her participating.       
    
